Longitudinal study of survival and causes of death in patients with thalassemia major in Greece

Annals of the New York Academy of Sciences

Volumn 1054, Issue , 2005, Pages 445-450

  Ladis, Vassilis ^a,b   Chouliaras, George ^a   Berdousi, Helen ^a   Kanavakis, Emmanuel ^a   Kattamis, Christos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Causes of death; Greece; Survival; Thalassemia major

Indexed keywords

FERRITIN;

ADULT; BLOOD TRANSFUSION; CAUSE OF DEATH; CHELATION THERAPY; CLINICAL CLASSIFICATION; CONFERENCE PAPER; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GREECE; HEART FAILURE; HEMOSIDEROSIS; HUMAN; KAPLAN MEIER METHOD; LIFE EXPECTANCY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATIENT CODING; PROBABILITY; RELIABILITY; RISK FACTOR; SEPSIS; SURVIVAL TIME; THALASSEMIA MAJOR;

EID: 29744463847     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1345.067     Document Type: Conference Paper

References (7)

1. LADIS, V., A. PAPADOPOULOU, C. ATHANASSAKI, et al. 1997. Long term survival and causes of death in patients with thalassemia major under conventional treatment. Bone Marrow Transplant. 19(Suppl. 2): 4-6.
2. BORGNA-PIGNATTI, C., S. RUGOLOTO, P. DE STEFANO, et al. 1998. Survival and disease complications in thalassemia major. Ann. N.Y. Acad. Sci. 850: 227-231.
3. MODELL, B., M. KHAN & M. DARLISON. 2000. Survival in β-thalassemia major in the UK: data from the UK Thalassemia Register. Lancet 355: 2051-2052.
4. EHLERS, K.H., P.J. GIARDINA, M.L. LESSER, et al. 2003. Prolonged survival in patients with beta-thalassemia major treated with deferoxamine. J. Pediatr. 118: 540-545.
5. PORTER, J.B. & B.A. DAVIS. 2002. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract. Res. Clin. Haematol. 15: 329-368.
6. KATTAMIS, C., H. HU, G. CHENG, et al. 1990. Molecular characterization of β-thalassemia in 174 Greek patients with thalassemia major. Br. J. Haematol. 74: 342-346.
7. KATTAMIS, A., C.H. KASSOU, H. BERDOUSI, et al. 2003. Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion. Haematologica 88: 1423-1425.